US-based microvascular products maker Micro Medical Solutions (MMS) has obtained CE mark approval for its microvascular device MicroStent, which enables the marketing of the technology in Europe.

MicroStent is a vascular stent developed to minimise below-the-knee amputations for critical limb ischemia (CLI) caused due to peripheral artery disease.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The stent is the centerpiece of an integrated delivery platform and aids amputation prevention in patients with CLI.

"The stent is the centerpiece of an integrated delivery platform and aids amputation prevention in patients with CLI."

Micro Medical Solutions chief executive officer Gregory Sullivan said: "This major milestone for MMS brings our Micro Vascular Integrated Platform, which includes MicroStent, one step closer to becoming available to European physicians.

"We are delighted to share this exciting news with interventionists, who are seeking much-needed innovation in this underserved area."

See Also:

The micro vascular integrated platform (mVIP) of the firm was commenced to develop technologies for the optimal treatment of CLI lesions below the knee as well as to minimise the risk of amputation.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The mVIP includes MicroBalloon and MicroGuide, in addition to the MicroStent. The MicroBalloon and MicroGuide have also received CE mark and 510(k) clearances.

MMS Regulatory and Clinical Affairs director Greg Mathison said that the firm intends to report data from a US clinical trial of the stent this year.

Micro Medical Solutions focuses on developing products to decrease the rate of amputations, improve clinical outcomes and patient quality of life, as well as reduce the financial and human costs for the treatment of peripheral artery disease and CLI.